|
|
 |
|
Viewing report
|
|
|
|
China's Pharmaceutical Industry - Porter's Five Forces Strategy Analysis
Aruvian's R'search, March 2011, Pages: 20
The Chinese pharmaceuticals market is forecast to become the world's firth largest by 2010 - and the largest by 2050. There are still greater market access following China's entry into the World Trade Organization (WTO), multinational investors continue to face a range of obstacles, many of which stem from the legacy of central planning of the industry. These include complex distribution, under-developed retail options, intellectual property infringements and pricing controls and pressures. At the same time, the continuing reliance of leading domestic companies on generic drugs has prevented the emergence of Chinese brands.
However, the industry is still small-scale, with a scattered geographical layout, duplicated production processes, and outdated manufacturing technology and management structure. The Chinese pharmaceutical industry also has a lower market concentration and weak international trading competitiveness, coupled with a lack of patented pharmaceuticals developed in-house.
Aruvian's R'search analyzes China’s Pharmaceutical Industry in Michael Porter’s Five Forces Analysis. It uses concepts developed in Industrial Organization (IO) economics to derive five forces that determine the competitive intensity and therefore attractiveness of a market. Porter referred to these forces as the microenvironment, to contrast it with the more general term macro-environment. They consist of those forces close to a company that affect its ability to serve its customers and make a profit. A change in any of the forces normally requires a company to re-assess the marketplace.
Customers who bought this item also bought
Pharmaceutical Industry in the United States - Porter's Five Forces Strategy Analysis
China's Pharmaceutical Industry - Porter's Five Forces Strategy Analysis
Pharmaceutical Industry in India - Porter's Five Forces Strategy Analysis
Canada's Pharmaceutical Industry - Porter's Five Forces Strategy Analysis
Pharmaceutical Industry in UK - Porter's Five Forces Strategy Analysis
Canada Pharmaceutical Industry
Pharmaceutical Industry in China
Drug Industry in the United States - Porter's Five Forces Strategy Analysis
Outlook of China Drug Formulation Market
Pharmaceutical Industry in China
|
|
|
|
